Gossamer Bio Option to Acquire Respira Therapeutics

Aileron Therapeutics Acquires Lung Therapeutics

October 31, 2023

Biotechnology

Aileron Therapeutics, Inc. (NASDAQ: ALRN) completed a stock-for-stock acquisition of Lung Therapeutics, Inc., bringing the clinical-stage pulmonary and fibrosis-focused pipeline (including lead candidate LTI-03) into Aileron's portfolio. Immediately after the acquisition Aileron arranged a private placement led by Bios Partners (with participation from Nantahala Capital and others) to raise approximately $18 million to fund ongoing development, including a Phase 1b trial of LTI-03.

Esperion Therapeutics to Acquire Corstasis Therapeutics

March 5, 2026

Biotechnology

Esperion Therapeutics announced it has entered into a definitive agreement to acquire Corstasis Therapeutics for an upfront cash payment of $75 million, with potential milestone payments of up to $180 million. The deal is expected to add Enbumyst (bumetanide nasal spray) to Esperion’s cardiovascular portfolio, leveraging its commercial infrastructure to expand its cardiovascular franchise.

ZOLL Medical Corporation Acquires Respicardia, Inc.

April 12, 2021

Medical Devices

ZOLL Medical Corporation, an Asahi Kasei company, acquired Respicardia, Inc., the developer of the implantable remēde® System for treating moderate to severe Central Sleep Apnea (CSA). The acquisition brings Respicardia’s FDA-approved neurostimulation technology and employees into ZOLL’s cardiac and respiratory care portfolio to expand treatment capabilities and global reach.

GSK To Acquire RAPT Therapeutics in $2.2 Billion Deal

January 23, 2026

Biotechnology

GSK signed a definitive agreement to acquire RAPT Therapeutics for an aggregate equity value of about $2.2 billion, expanding its Respiratory, Immunology & Inflammation pipeline. The deal adds ozureprubart, a long-acting anti-IgE monoclonal antibody in Phase IIb development for prophylaxis of food-allergy reactions.

SunMed Acquires Vyaire Medical's Respiratory & Anesthesia Consumables Business

March 28, 2023

Medical Devices

SunMed, a Frazier Healthcare Partners–backed medical-device manufacturer headquartered in Grand Rapids, Michigan, agreed to acquire Vyaire Medical’s respiratory and anesthesia consumables business, a unit that makes airway management and operative-care consumables. The deal—announced March 28, 2023 and completed May 1, 2023—expands SunMed’s product portfolio, manufacturing footprint and global reach; terms were not disclosed.

SunMed (AirLife) Acquires Avanos Medical's Respiratory Health Business

June 8, 2023

Medical Devices

SunMed (doing business as AirLife) agreed to acquire Avanos Medical's Respiratory Health business, including the BALLARD, MICROCUFF and endOclear brands and two manufacturing facilities in Mexico. The deal (announced June 8, 2023 and completed Oct 2023) expands SunMed's anesthesia and respiratory consumables portfolio and transfers related R&D and manufacturing capabilities from Avanos as part of Avanos' broader transformation.